Sionna Therapeutics, Inc. (SION)
5.59
+0.30
(+5.67%)
USD |
NASDAQ |
Aug 24, 16:00
5.55
-0.04
(-0.72%)
After-Hours: 20:00
Sionna Therapeutics Total Assets (Quarterly) : 283.25M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 283.25M |
| March 31, 2026 | 305.04M |
| December 31, 2025 | 327.93M |
| September 30, 2025 | 339.27M |
| June 30, 2025 | 352.05M |
| March 31, 2025 | 369.67M |
| Date | Value |
|---|---|
| December 31, 2024 | 185.75M |
| September 30, 2024 | 197.26M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 51.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 27.42B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Immunic, Inc. | 159.17M |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.47M |
| Shareholders Equity (Quarterly) | 265.78M |
| Debt to Equity Ratio | 0.0304 |
| Current Ratio | 20.05 |
| Net Debt Paydown Yield | 0.01% |